UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004780
Receipt number R000005683
Scientific Title Randamized phase II trial of S-1+CDDP vs S-1+Docetaxel for advanced and/or recurrent gastric cancer
Date of disclosure of the study information 2011/01/15
Last modified on 2015/06/22 09:43:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randamized phase II trial of S-1+CDDP vs S-1+Docetaxel for advanced and/or recurrent gastric cancer

Acronym

CS vs DS for GC

Scientific Title

Randamized phase II trial of S-1+CDDP vs S-1+Docetaxel for advanced and/or recurrent gastric cancer

Scientific Title:Acronym

CS vs DS for GC

Region

Japan


Condition

Condition

advanced and/or recurrent gastric cancer

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Non-recessive study compared the efficacy and the safety between the S-1+CDDP and S-1 + Docetaxel

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Time to progression

Key secondary outcomes

Median survival time
Response rate
The rate of adverse event
Median rate of continuing therapy


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Group A: 1 cycle is consited of 5 weeks used S-1+CDDP

Interventions/Control_2

Group B: 1 cycle is consisted of 3 weeks used S-1 + Docetaxel

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1.Histologically proven adenocarcinoma of advanced gastric cancer(included esophagogastric junction)
2.Oral intake is possible
3.Presence of clear lesion for mesure
4.Performance status 0 to 1(ECOG)
5.Hemoglobin less than 8 g/dl, WBC counts is between 12000 and 4000
6.s-Creatinin level within normal limit
7.s-Bilirubin level within 1.5 X normal limit
8.S-GOT/GPT within 2.5Xnormal limit
9.Alkaline phosphatase within 2.5Xnormal limit
10.Without surgical influence
11.Witjout previous chemotherapy
12.Life expectancy is less than 3 months
13.Written informed conscent

Key exclusion criteria

1.With active other cancer(excluded early colonic cancer)
2.With active bleeding
3.With ascites needed to exclude
4.metastasis to the brain
5.With peripheral neuropathy more than
Grade 2
6.Interstitial pneumonia
7.With erethism history for 5-FU, TXT, polisorbate 80
8.Previouslly treated by chemoradiation
9.pregnancy and the person of intention to become pregnant
10. participated in other trial wiyhin 4 weeks
11.forbidden to use steroid

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hirai Toshihiro

Organization

Kawasaki Medical University

Division name

Department of Digestive Surgery

Zip code


Address

81-86-462-1111

TEL

086-462-1111

Email

hiro0928@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hideo Matsumoto

Organization

Kawasaki Medical University

Division name

Department of Digestive surgery

Zip code


Address

577 Matsushima Kurashiki Okayama

TEL

086-462-1111

Homepage URL


Email

h-matsu@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Department of Digestive Surgery, Kawasaki Medical University

Institute

Department

Personal name



Funding Source

Organization

Department of Digestive Surgery, Kawasaki Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2011 Year 01 Month 10 Day

Date of IRB


Anticipated trial start date

2011 Year 01 Month 01 Day

Last follow-up date

2013 Year 01 Month 01 Day

Date of closure to data entry

2014 Year 02 Month 01 Day

Date trial data considered complete

2014 Year 02 Month 01 Day

Date analysis concluded

2015 Year 01 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 12 Month 22 Day

Last modified on

2015 Year 06 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005683


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name